Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Project
Preclinical evaluation of synergistic drug interactions with CDK12-controlled DNA damage response signaling as potential therapy for high-risk neuroblastoma
Information
Project Team
Outputs and Outcomes
Promotor
Kaat Durinck
Department of Biomolecular Medicine
